Denali Therapeutics, Inc. (DNLI)
18.41
-0.25
(-1.34%)
USD |
NASDAQ |
Oct 23, 16:00
18.40
0.00 (0.00%)
After-Hours: 20:00
Denali Therapeutics Market Cap : 2.941B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.941B |
| October 22, 2026 | 2.981B |
| October 21, 2026 | 2.984B |
| October 20, 2026 | 3.024B |
| October 19, 2026 | 2.882B |
| October 16, 2026 | 2.813B |
| October 15, 2026 | 2.930B |
| October 14, 2026 | 2.855B |
| October 13, 2026 | 2.940B |
| October 12, 2026 | 3.027B |
| October 09, 2026 | 3.107B |
| October 08, 2026 | 2.983B |
| October 07, 2026 | 3.061B |
| October 06, 2026 | 3.080B |
| October 05, 2026 | 3.181B |
| October 02, 2026 | 3.195B |
| October 01, 2026 | 3.280B |
| September 30, 2026 | 3.302B |
| September 29, 2026 | 3.325B |
| September 28, 2026 | 3.352B |
| September 25, 2026 | 3.257B |
| September 24, 2026 | 3.270B |
| September 23, 2026 | 3.269B |
| September 22, 2026 | 3.451B |
| September 21, 2026 | 3.270B |
| Date | Value |
|---|---|
| September 18, 2026 | 3.150B |
| September 17, 2026 | 3.216B |
| September 16, 2026 | 3.205B |
| September 15, 2026 | 3.256B |
| September 14, 2026 | 3.390B |
| September 11, 2026 | 3.369B |
| September 10, 2026 | 3.419B |
| September 09, 2026 | 3.446B |
| September 08, 2026 | 3.527B |
| September 04, 2026 | 3.559B |
| September 03, 2026 | 3.642B |
| September 02, 2026 | 3.650B |
| September 01, 2026 | 3.717B |
| August 31, 2026 | 3.796B |
| August 28, 2026 | 3.834B |
| August 27, 2026 | 3.941B |
| August 26, 2026 | 3.925B |
| August 25, 2026 | 3.983B |
| August 24, 2026 | 3.866B |
| August 21, 2026 | 3.981B |
| August 20, 2026 | 3.986B |
| August 19, 2026 | 4.104B |
| August 18, 2026 | 3.884B |
| August 17, 2026 | 3.890B |
| August 14, 2026 | 3.898B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.189B |
| Oncolytics Biotech, Inc. | 62.61M |
| Sangamo Therapeutics, Inc. | 47.64M |
| Sarepta Therapeutics, Inc. | 1.873B |
| Anixa Biosciences, Inc. | 103.41M |
Market Cap Related Metrics
| PS Ratio | 921.82 |
| PEG Ratio | -6.072 |
| Price to Book Value | 3.522 |
| Price | 18.41 |
| Earnings Yield | -15.41% |
| PEGY Ratio | -6.072 |